Amcor Other Non-Current Liabilities decreased by 7.7% to $710.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 73.2%, from $410.00M to $710.00M. Over 4 years (FY 2021 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 19.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $371.00M | $365.00M | $362.00M | $418.00M | $471.00M | $523.00M | $488.00M | $449.00M | $481.00M | $451.00M | $408.00M | $403.00M | $418.00M | $414.00M | $429.00M | $410.00M | $754.00M | $741.00M | $769.00M | $710.00M |
| QoQ Change | — | -1.6% | -0.8% | +15.5% | +12.7% | +11.0% | -6.7% | -8.0% | +7.1% | -6.2% | -9.5% | -1.2% | +3.7% | -1.0% | +3.6% | -4.4% | +83.9% | -1.7% | +3.8% | -7.7% |
| YoY Change | — | — | — | — | +27.0% | +43.3% | +34.8% | +7.4% | +2.1% | -13.8% | -16.4% | -10.2% | -13.1% | -8.2% | +5.1% | +1.7% | +80.4% | +79.0% | +79.3% | +73.2% |